Mark R. Burge, MD, is an established clinical and translational investigator in diabetes at the University of New Mexico HSC. His R01-funded studies have thus far focused on the physiology and pathophysiology of hypoglycemia in patients with type 2 diabetes and on improving treatments for individuals with type 1 and type 2 diabetes. He has also participated as a co-investigator at the New Mexico site in landmark diabetes-related clinical trials, including the Diabetes Control and Complications Trial (DCCT) and the Diabetes Prevention Program (DPP). Dr. Burge’s current research is aimed at establishing a comprehensive cohort of prediabetes subjects as a repository for future research studies. This work is supported by the Centers for Disease Control (CDC) and focuses on New Mexico populations that suffer disproportionately from health disparity.
Dr. Burge served as the longstanding Program Director of the UNM General Clinical Research Center (GCRC) and is currently the Deputy Director of UNM’s new Clinical and Translational Science Center (CTSC). Before that, he served as the Research Subject Advocate for the UNM GCRC, and he is well familiar with Data Safety and Monitoring requirements and the functions of a DSMB in the proposed study. He has also successfully applied for an IND in the past.
Dr. Burge is a recent past-President of the American Federation for Medical Research (AFMR) and current President of the Western Society for Clinical Investigation (WSCI).
selected publications as collaborator
- Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program. Diabetic medicine : a journal of the British Diabetic Association. 31:1064-1068. 2014
- Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program. Diabetologia. 57:935-939. 2014
- Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program. Diabetologia. 57:485-490. 2014
- Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence. The international journal of behavioral nutrition and physical activity. 11:-. 2014
- Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 62:3976-3986. 2013
- My research specializes in novel treatments for type 1 and type 2 diabetes, as well as investigations into the pathophysiology of acute and chronic complications of those diseases, with a special interest in hypoglycemia in type 2 diabetes.
education and training
awards and honors
- Fitz List, 2015
- (505) 272-5155
DoIM MSC 10-55501 University of New MexicoAlbuquerque, New Mexico 87131United States of America
eRA Commons id